Cargando…

CD39 molecule: a negative regulator expressed on T cells in patients with lung adenocarcinoma

INTRODUCTION: The function of cytotoxic cells may be impacted by CD39 expression on CD8-positive T lymphocytes, leading to an imbalance in tumor immunity. METHODS: We analyzed the correlation between the expression of CD39 on CD8-positive T lymphocytes and clinical information in 203 patients with l...

Descripción completa

Detalles Bibliográficos
Autores principales:	Tang, Lu, Jin, Hao
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Termedia Publishing House 2023
Materias:	Research Letter
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10507747/ https://www.ncbi.nlm.nih.gov/pubmed/37732039 http://dx.doi.org/10.5114/aoms/170959

Ejemplares similares

MicroRNA‐326 negatively regulates CD155 expression in lung adenocarcinoma
por: Nakanishi, Takayuki, et al.
Publicado: (2023)

CD39 Regulation and Functions in T Cells
por: Timperi, Eleonora, et al.
Publicado: (2021)

CD38(+)CD39(+) NK cells associate with HIV disease progression and negatively regulate T cell proliferation
por: Qian, Shi, et al.
Publicado: (2022)

In lung adenocarcinoma, low expression of the cell surface extracellular nucleotidase CD39 is related to immune infiltration and a poor prognosis
por: Shao, Lili, et al.
Publicado: (2022)

CD39: the potential target in small cell lung cancer
por: Chen, Shanhao, et al.
Publicado: (2020)

Enhanced expression of CD39 and CD73 on T cells in the regulation of anti-tumor immune responses
por: Shevchenko, Ivan, et al.
Publicado: (2020)

CD39 Expression Identifies Terminally Exhausted CD8(+) T Cells
por: Gupta, Prakash K., et al.
Publicado: (2015)

PMN‐MDSCs‐induced accumulation of CD8+CD39+ T cells predicts the efficacy of chemotherapy in esophageal squamous cell carcinoma
por: Qin, Guohui, et al.
Publicado: (2020)

CD39 is a negative regulator of P2X7-mediated inflammatory cell death in mast cells
por: Kuhny, Marcel, et al.
Publicado: (2014)

Ketamine induces apoptosis in lung adenocarcinoma cells by regulating the expression of CD69
por: Zhou, Xuhui, et al.
Publicado: (2018)

Evaluation of the prognostic values of solute carrier (SLC) family 39 genes for patients with lung adenocarcinoma
por: Zhou, Heng, et al.
Publicado: (2021)

Expression of CD39 on Activated T Cells Impairs their Survival in Older Individuals
por: Fang, Fengqin, et al.
Publicado: (2016)

Inhibitory Molecules PD-1, CD73 and CD39 Are Expressed by CD8(+) T Cells in a Tissue-Dependent Manner and Can Inhibit T Cell Responses to Stimulation
por: Smith, Corinne J., et al.
Publicado: (2021)

CD39(+) regulatory T cells accumulate in colon adenocarcinomas and display markers of increased suppressive function
por: Ahlmanner, Filip, et al.
Publicado: (2018)

Fingolimod Increases CD39-Expressing Regulatory T Cells in Multiple Sclerosis Patients
por: Muls, Nathalie, et al.
Publicado: (2014)

Rapamycin Regulates iTreg Function through CD39 and Runx1 Pathways
por: Lu, Yunjie, et al.
Publicado: (2014)

Expression of PD-1 by CD4(+)CD25(+)CD127(low) Treg cells in the peripheral blood of lung cancer patients
por: Zhong, AnYuan, et al.
Publicado: (2015)

CD133 expression in different stages of gastric adenocarcinoma
por: Boegl, M, et al.
Publicado: (2009)

RFX1 regulates CD70 and CD11a expression in lupus T cells by recruiting the histone methyltransferase SUV39H1
por: Zhao, Ming, et al.
Publicado: (2010)

Reply: CD133 expression in different stages of gastric adenocarcinoma
por: Smith, L M, et al.
Publicado: (2009)

Expression of CD39 on FoxP3(+ )T regulatory cells correlates with progression of HBV infection
por: Tang, Yan, et al.
Publicado: (2012)

Low expression of CD39 and CD73 genes in centenarians compared with octogenarians
por: Crooke, Almudena, et al.
Publicado: (2017)

Exploring CD39 and CD73 Expression as Potential Biomarkers in Prostate Cancer
por: Gardani, Carla Fernanda Furtado, et al.
Publicado: (2023)

Identification of SUV39H2 as a potential oncogene in lung adenocarcinoma
por: Zheng, Yu, et al.
Publicado: (2018)

The ectonucleotidases CD39 and CD73 on T cells: The new pillar of hematological malignancy
por: Jiang, Xuan, et al.
Publicado: (2023)

Dysfunctional subsets of CD39+ T cells, distinct from PD-1+, driven by leukemic extracellular vesicles in myeloid leukemias
por: Swatler, Julian, et al.
Publicado: (2022)

Ectonucleotidase CD39 is highly expressed on ATLL cells and is responsible for their immunosuppressive function
por: Nagate, Yasuhiro, et al.
Publicado: (2020)

GPR39 deorphanization: The long and winding road to eicosanoids and a crosstalk between GPR39 and hedgehog signaling in angiogenesis
por: Doboszewska, Urszula, et al.
Publicado: (2023)

STK11 mutation impacts CD1E expression to regulate the differentiation of macrophages in lung adenocarcinoma
por: Zhang, Qingfeng, et al.
Publicado: (2023)

MDSC subtypes and CD39 expression on CD8(+) T cells predict the efficacy of anti‐PD‐1 immunotherapy in patients with advanced NSCLC
por: Koh, Jiae, et al.
Publicado: (2020)

Is the purinergic pathway involved in the pathology of COPD? Decreased lung CD39 expression at initial stages of COPD
por: Aliagas, Elisabet, et al.
Publicado: (2018)

Adenosine generation catalyzed by CD39 and CD73 expressed on regulatory T cells mediates immune suppression
por: Deaglio, Silvia, et al.
Publicado: (2007)

High Expression of Ecto-Nucleotidases CD39 and CD73 in Human Endometrial Tumors
por: Aliagas, Elisabet, et al.
Publicado: (2014)

Co-expression of CD39 and CD103 identifies tumor-reactive CD8 T cells in human solid tumors
por: Duhen, Thomas, et al.
Publicado: (2018)

CD39 pathway inhibits Th1 cell function in tuberculosis
por: Luo, Ying, et al.
Publicado: (2022)

Endogenous antisense RNA curbs CD39 expression in Crohn’s disease
por: Harshe, Rasika P., et al.
Publicado: (2020)

Pronounce expression of Tim-3 and CD39 but not PD1 defines CD8 T cells in critical Covid-19 patients
por: Shahbazi, Mehdi, et al.
Publicado: (2021)

High Expression of CD39 is Associated with Poor Prognosis and Immune Infiltrates in Clear Cell Renal Cell Carcinoma
por: Wu, Jie, et al.
Publicado: (2020)

Resident Cardiac Immune Cells and Expression of the Ectonucleotidase Enzymes CD39 and CD73 after Ischemic Injury
por: Bönner, Florian, et al.
Publicado: (2012)

Expression of CD39 Identifies Activated Intratumoral CD8+ T Cells in Mismatch Repair Deficient Endometrial Cancer
por: Lubbers, Joyce M., et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_0nd47sffnn31quc3jac3r78obb